Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$115.00
Provider: Wright Reports
$75.00
Provider: New Constructs, LLC
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Heska Corp Announces Sale Of Non-Core Assets To Eli Lilly and Co's Division


Monday, 24 Jun 2013 09:00am EDT 

Heska Corp announced the sale of certain non-core assets useful for the production of both bovine and feline vaccines to Elanco Animal Health, a division of Eli Lilly and Co. Heska does not anticipate any change in its current bovine and feline vaccine production at its wholly-owned facility in Des Moines, Iowa as a result of the agreement with Elanco. Financial terms were not disclosed. 

Company Quote

59.56
-0.47 -0.78%
23 Apr 2014